Latest Investments News

Orthocell’s nerve repair device Remplir is being adopted in Australia for nerve-sparing prostate cancer surgeries, aiming to reduce erectile dysfunction and urinary incontinence post-operation. This development could significantly expand Remplir’s market reach globally.

Bridgeport Energy reports stable petroleum reserves of 4.1 million barrels of oil equivalent and 4.9 million barrels of contingent resources as of July 2025, underpinning its ongoing production and future gas development plans.

Medallion Metals has taken a crucial step forward by ordering a secondary ball mill to upgrade the Cosmic Boy Concentrator, underpinning its Sulphide Production Strategy and advancing its feasibility study toward a final investment decision.

Tesoro Gold has released an expanded and upgraded scoping study for its Ternera open pit project in Chile, revealing strong economics and a 1.82 million ounce gold resource. The study highlights a straightforward development path with low capital costs and excellent gold recoveries.

Eclipse Metals has launched a significant drilling campaign in Greenland, targeting rare earth elements at its Ivigtût and Grønnedal sites amid rising global demand for critical minerals.

Paladin Energy has launched a fully underwritten A$300 million equity raising to advance its Patterson Lake South uranium project, aiming for a Final Investment Decision and first production by 2031.

Sunrise Energy Metals has attracted a significant financing interest from the U.S. Export-Import Bank, potentially securing half the capital needed for its Syerston Scandium Project amid shifting global supply dynamics.

Magnetic Resources NL has secured all necessary mining leases for its Lady Julie Gold Project, marking a critical step towards production. Supported by a robust feasibility study and a recent resource upgrade, the project is now development-ready.

New Hope Corporation reported an 18.1% rise in coal production for FY25 alongside an 8.4% reduction in unit costs, declaring a fully franked 15-cent dividend and launching a Dividend Reinvestment Plan.

New Hope Corporation Limited has unveiled a Dividend Reinvestment Plan (DRP) offering eligible Australian and New Zealand shareholders a flexible, fee-free way to reinvest dividends into additional shares. The plan empowers investors to grow their holdings conveniently while maintaining control over participation levels.

CSL Limited has partnered with Dutch biotech VarmX to develop VMX-C001, a novel treatment aimed at reversing bleeding in patients on FXa inhibitors, with FDA Fast Track status and a potential 2029 launch.

Pinnacle Investment Management has updated its dividend distribution details, confirming a fully franked ordinary dividend of AUD 0.27 per share and setting the Dividend Reinvestment Plan price at AUD 18.706.